Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 215

Similar articles for PubMed (Select 23948894)

1.

Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease.

Handels RL, Xu W, Rizzuto D, Caracciolo B, Wang R, Winblad B, Verhey FR, Severens JL, Fratiglioni L, Joore MA, Wimo A.

J Alzheimers Dis. 2013;37(2):357-65. doi: 10.3233/JAD-130296.

PMID:
23948894
2.
3.

The advanced activities of daily living: a tool allowing the evaluation of subtle functional decline in mild cognitive impairment.

De Vriendt P, Gorus E, Cornelis E, Bautmans I, Petrovic M, Mets T.

J Nutr Health Aging. 2013 Jan;17(1):64-71. doi: 10.1007/s12603-012-0381-9.

PMID:
23299382
4.

Accelerated progression from mild cognitive impairment to dementia among APOE ε4ε4 carriers.

Xu WL, Caracciolo B, Wang HX, Santoni G, Winblad B, Fratiglioni L.

J Alzheimers Dis. 2013;33(2):507-15. doi: 10.3233/JAD-2012-121369.

PMID:
23247007
5.

Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls.

Schrijnemaekers AM, de Jager CA, Hogervorst E, Budge MM.

J Clin Exp Neuropsychol. 2006 Apr;28(3):438-55.

PMID:
16618630
6.

[A three-year follow-up study on the transfer of mild cognitive impairment to Alzheimer's disease among the elderly in Taiyuan city].

Wang YP, Zhai JB, Zhu F, Zhang WW, Yang XJ, Qu CY.

Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Feb;32(2):105-9. Chinese.

PMID:
21518614
7.

A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment.

Yu L, Boyle P, Wilson RS, Segawa E, Leurgans S, De Jager PL, Bennett DA.

Neuroepidemiology. 2012;39(2):73-83. doi: 10.1159/000339365. Epub 2012 Jul 17.

8.

Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative.

Song X, Mitnitski A, Zhang N, Chen W, Rockwood K; Alzheimer's Disease Neuroimaging Initiative.

J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):71-8. doi: 10.1136/jnnp-2012-303579. Epub 2012 Nov 2.

PMID:
23123510
9.

Estimation of the risk of conversion of mild cognitive impairment of Alzheimer type to Alzheimer's disease in a south Brazilian population-based elderly cohort: the PALA study.

Godinho C, Camozzato AL, Onyszko D, Chaves ML.

Int Psychogeriatr. 2012 Apr;24(4):674-81. doi: 10.1017/S1041610211002043. Epub 2011 Nov 17.

PMID:
22088617
10.

The epidemiology of mild cognitive impairment (MCI) and Alzheimer's disease (AD) in community-living seniors: protocol of the MemoVie cohort study, Luxembourg.

Perquin M, Schuller AM, Vaillant M, Diederich N, Bisdorff A, Leners JC, D'Incau M, Ludewig JL, Hoffmann D, Ulbricht D, Thoma S, Dondelinger R, Heuschling P, Couffignal S, Dartigues JF, Lair ML.

BMC Public Health. 2012 Jul 12;12:519. doi: 10.1186/1471-2458-12-519.

11.

Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease.

Teixeira AL, Diniz BS, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV.

Neuromolecular Med. 2013 Mar;15(1):115-21. doi: 10.1007/s12017-012-8201-2. Epub 2012 Sep 28.

PMID:
23055000
12.

An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.

Zhang N, Song X, Zhang Y, Chen W, D'Arcy RC, Darvesh S, Fisk JD, Rockwood K; Alzheimer's disease Neuroimaging Initiative.

J Alzheimers Dis. 2011;26 Suppl 3:359-67. doi: 10.3233/JAD-2011-0048.

PMID:
21971475
13.

Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study.

Gattaz WF, Talib LL, Schaeffer EL, Diniz BS, Forlenza OV.

J Neural Transm. 2014 Feb;121(2):193-200. doi: 10.1007/s00702-013-1088-8. Epub 2013 Sep 15.

PMID:
24036895
14.

Smell identification function as a severity and progression marker in Alzheimer's disease.

Velayudhan L, Pritchard M, Powell JF, Proitsi P, Lovestone S.

Int Psychogeriatr. 2013 Jul;25(7):1157-66. doi: 10.1017/S1041610213000446. Epub 2013 Apr 19.

PMID:
23597130
15.

Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm.

Agüero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B.

J Am Geriatr Soc. 1998 Apr;46(4):444-52.

PMID:
9560066
16.

Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.

Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ.

Neurology. 1998 Aug;51(2):351-7.

PMID:
9710002
17.

Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.

Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O, Boada M, Bullock R, De Deyn PP, Frisoni GB, Hampel H, Jones RW, Kehoe P, Lenoir H, Minthon L, Olde Rikkert MG, Rodriguez G, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Verhey FR, Winblad B, Wahlund LO, Wilcock G, Visser PJ.

Dement Geriatr Cogn Disord. 2013;36(1-2):1-19. doi: 10.1159/000348354. Epub 2013 May 3.

PMID:
23651945
18.

Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.

Soto ME, van Kan GA, Nourhashemi F, Gillette-Guyonnet S, Cesari M, Cantet C, Rolland Y, Vellas B.

J Am Geriatr Soc. 2013 Sep;61(9):1482-8. doi: 10.1111/jgs.12415. Epub 2013 Sep 3.

PMID:
24000874
19.

Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.

Conde-Sala JL, Garre-Olmo J, Vilalta-Franch J, Llinàs-Reglà J, Turró-Garriga O, Lozano-Gallego M, Hernández-Ferrándiz M, Pericot-Nierga I, López-Pousa S.

Int Psychogeriatr. 2012 Jun;24(6):948-58. doi: 10.1017/S1041610211002158. Epub 2012 Jan 26.

PMID:
22278151
20.

Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.

Defrancesco M, Marksteiner J, Deisenhammer E, Kemmler G, Djurdjevic T, Schocke M.

J Alzheimers Dis. 2013;34(3):665-72. doi: 10.3233/JAD-122095.

PMID:
23254639
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk